China Arrests Five SFDA Officials On Bribery Charges
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Chinese authorities earlier this month arrested five officials from the State FDA and the National Institute for the Control of Pharmaceutical and Biological Products for taking bribes, according to reports by the government-run Xinhua News Agency
You may also be interested in...
Former Deputy Director Of China's Drug Regulatory Agency Could Face Trial On Corruption Charges
BEIJING - Eight months after coming under scrutiny of the Chinese Communist Party's top anti-corruption commission, a deputy director of China's State FDA has been expelled from the Party and could face trial, according to central government officials
Former Deputy Director Of China's Drug Regulatory Agency Could Face Trial On Corruption Charges
BEIJING - Eight months after coming under scrutiny of the Chinese Communist Party's top anti-corruption commission, a deputy director of China's State FDA has been expelled from the Party and could face trial, according to central government officials
3SBIO Sees Slowdown In China Regulatory Approvals Following SFDA Restructure; Concerns Linger On Drug Pricing Examination
SHANGHAI - Chinese biotech outfit 3SBio reported strong sales growth of its key products, recombinant human erythropoietin injection EPIAO and recombinant human thrombopoietin injection TPIAO, but like many companies in China, 3SBio's development plans are impacted by a regulatory slowdown caused by restructuring at China's State FDA